Skip to main content
    • Aa
    • Aa

Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis

  • O. Mason (a1), C. J. A. Morgan (a1), S. K. Dhiman (a1), A. Patel (a1), N. Parti (a1), A. Patel (a1) and H. V. Curran (a1)...

Epidemiological evidence suggests a link between cannabis use and psychosis. A variety of factors have been proposed to mediate an individual's vulnerability to the harmful effects of the drug, one of which is their psychosis proneness. We hypothesized that highly psychosis-prone individuals would report more marked psychotic experiences under the acute influence of cannabis.


A group of cannabis users (n=140) completed the Psychotomimetic States Inventory (PSI) once while acutely intoxicated and again when free of cannabis. A control group (n=144) completed the PSI on two parallel test days. All participants also completed a drug history and the Schizotypal Personality Questionnaire (SPQ). Highly psychosis-prone individuals from both groups were then compared with individuals scoring low on psychosis proneness by taking those in each group scoring above and below the upper and lower quartiles using norms for the SPQ.


Smoking cannabis in a naturalistic setting reliably induced marked increases in psychotomimetic symptoms. Consistent with predictions, highly psychosis-prone individuals experienced enhanced psychotomimetic states following acute cannabis use.


These findings suggest that an individual's response to acute cannabis and their psychosis-proneness scores are related and both may be markers of vulnerability to the harmful effects of this drug.

Corresponding author
*Address for correspondence: Professor H. V. Curran, Clinical Psychopharmacology Unit, Clinical Health Psychology, University College London, Gower Street, London WC1E 6BT, UK. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

E Barkus , S Lewis (2008). Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample. Psychological Medicine. Published online: 21 January 2008. doi:10.1017/S0033291707002619.

E Barkus , J Stirling , R Hopkins , S Lewis (2006). Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 39, 139178.

DC D'Souza , E Perry , L MacDougall , Y Ammerman , T Cooper , YT Wu , G Braley , R Gueorguieve , JH Krystal (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for research. Neuropsychopharmacology 29, 15581572.

M Di Forti , PD Morrison , A Butt , RM Murray (2007). Cannabis use and psychiatric and cognitive disorders: the chicken or the egg? Current Opinion in Psychiatry 20, 228234.

B Favrat , A Ménétrey , M Augsburger , LE Rothuizen , M Appenseller , T Buclin , M Pin , P Mangin , C Giroud (2005). Two cases of ‘cannabis acute psychosis’ following the administration of oral cannabis. BMC Psychiatry 5, 1719.

DM Fergusson , LJ Horwood , EM Ridder (2005). Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 100, 354366.

C Henquet , L Krabbendam , J Spauwen , C Kaplan , R Lieb , HU Wittchen , J van Os (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 330, 1115.

M Hickman , P Vickerman , J Macleod , J Kirkbride , PB Jones (2007) Cannabis and schizophreia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia. Addiction 102, 597606.

OJ Mason , CJA Morgan , A Stefanovic , HV Curran (2008). The Psychotomimetic States Inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis. Schizophrenia Research 103, 138142.

THM Moore , S Zammit , A Lingford-Hughes , TRE Barnes , PB Jones , M Burke , L Lewis (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319328.

CJA Morgan , HV Curran (2008). Effects of cannabidiol on schizophrenia-like symptoms in cannabis users. British Journal of Psychiatry 192, 306307.

CJA Morgan , S Rossell , F Pepper , J Smart , J Blackburn , B Brandner , HV Curran (2006). Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Biological Psychiatry 59, 265272.

A Raine (1991). The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin 17, 555564.

PD Skosnik , L Spatz-Glenn , S Park (2001). Cannabis use is associated with schizotypy and attentional disinhibition. Schizophrenia Research 48, 8392.

A Soliman , GA O'Driscoll , J Pruessner , ALV Holahan , I Boileau , D Gagnon , A Dagher (2007). Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study. Neuropsychopharmacology. Published online: 24 October 2007. doi:10.1038/sj.npp.1301597.

UNODC (2007). World Drug Report. United Nations Office on Drugs and Crime, 2007. Vienna, Austria.

JH Williams , NA Wellman , JNP Rawlins (1996). Cannabis use correlates with schizotypy in healthy people. Addiction 91, 869878.

S Zammit , G Spurlock , H Williams , N Norton , N Williams , MC O'Donovan , MJ Owen (2007). Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. British Journal of Psychiatry 191, 402407.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *